0 items USD 0.00Search
Your search for "gbi research global rheumatic disorders drugs market 2024 increased uptake il inhibitors jak" gave back 83406 results.
Anaphylaxis is an inappropriate reaction of the immune system to normal harmless substances. It generally has a rapid onset, strong reaction, and...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy...
Catalog:
LPI
March 2023
Price: USD 3,660.00
JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
JAK inhibitor I is a JAK1/2/3 inhibitor that decreased cell proliferation in breast cancer cells, increased apoptosis in esophageal squamous cell...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Janus kinase inhibitors are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global JAK1 Inhibitor Drug market size is expected to reach $ 16550 million by 2029, rising at a market growth of 7.5% CAGR during the forecast...
Catalog:
GIR
August 2023
Price: USD 4,480.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
JAK inhibitor I is a JAK1/2/3 inhibitor that decreased cell proliferation in breast cancer cells, increased apoptosis in esophageal squamous cell...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global JAK1 Inhibitor Drug market size is projected to grow from US$ 9503.7 million in 2022 to US$ 16380 million in 2029; it is expected to grow...
Catalog:
LPI
July 2023
Price: USD 3,660.00
JAK1 inhibitor drugs are a class of medications that specifically target the Janus kinase 1 (JAK1) enzyme. These drugs work by blocking the activity...
Catalog:
MRRPB5
August 2023
Price: USD 2,900.00
JAK inhibitor I is a JAK1/2/3 inhibitor that decreased cell proliferation in breast cancer cells, increased apoptosis in esophageal squamous cell...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
Catalog:
LPI
February 2023
Price: USD 3,660.00
